NuVasive Total Assets 2006-2018 | NUVA

NuVasive total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
NuVasive Annual Total Assets
(Millions of US $)
2018 $1,708
2017 $1,640
2016 $1,571
2015 $1,303
2014 $1,342
2013 $1,180
2012 $1,164
2011 $1,124
2010 $802
2009 $653
2008 $487
2007 $226
2006 $196
2005 $71
NuVasive Quarterly Total Assets
(Millions of US $)
Q4 2018 $1,708
Q3 2018 $1,675
Q2 2018 $1,672
Q1 2018 $1,671
Q4 2017 $1,640
Q3 2017 $1,629
Q2 2017 $1,606
Q1 2017 $1,570
Q4 2016 $1,571
Q3 2016 $1,636
Q2 2016 $1,606
Q1 2016 $1,569
Q4 2015 $1,303
Q3 2015 $1,272
Q2 2015 $1,286
Q1 2015 $1,296
Q4 2014 $1,342
Q3 2014 $1,269
Q2 2014 $1,254
Q1 2014 $1,225
Q4 2013 $1,180
Q3 2013 $1,140
Q2 2013 $1,108
Q1 2013 $1,101
Q4 2012 $1,164
Q3 2012 $1,185
Q2 2012 $1,167
Q1 2012 $1,149
Q4 2011 $1,124
Q3 2011 $1,115
Q2 2011 $1,273
Q1 2011 $807
Q4 2010 $802
Q3 2010 $711
Q2 2010 $686
Q1 2010 $666
Q4 2009 $653
Q3 2009 $633
Q2 2009 $599
Q1 2009 $525
Q4 2008 $487
Q3 2008 $469
Q2 2008 $453
Q1 2008 $447
Q4 2007 $226
Q3 2007 $216
Q2 2007 $210
Q1 2007 $207
Q4 2006 $196
Q3 2006 $194
Q2 2006 $208
Q1 2006 $210
Q4 2005 $71
Q3 2005 $74
Q2 2005 $83
Q1 2005 $80
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.870B $1.102B
NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $130.875B 25.52
Medtronic (MDT) Ireland $112.858B 16.50
Stryker (SYK) United States $67.965B 24.92
Boston Scientific (BSX) United States $48.570B 23.60
Baxter (BAX) United States $38.462B 24.67
Zimmer Biomet Holdings (ZBH) United States $24.795B 15.86
Canopy Growth (CGC) Canada $16.605B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.541B 0.00
ResMed (RMD) United States $14.331B 27.18
Aurora Cannabis (ACB) Canada $9.351B 65.93
Bio-Rad Laboratories (BIO) United States $8.746B 50.17
Perrigo (PRGO) Ireland $6.654B 10.79
Hill-Rom Holdings (HRC) United States $6.265B 19.38
Insulet (PODD) United States $4.918B 1648.60
GW Pharmaceuticals (GWPH) United Kingdom $4.886B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.248B 37.69
Hutchison China MediTech (HCM) China $4.058B 0.00
Agios Pharmaceuticals (AGIO) United States $3.323B 0.00
Neogen (NEOG) United States $2.935B 47.73
Quidel (QDEL) United States $2.395B 21.43
National Vision Holdings (EYE) United States $2.233B 43.92
Aphria (APHA) $1.970B 0.00
HEXO (HEXO) $1.493B 0.00
Phibro Animal Health (PAHC) United States $1.350B 19.40
Cardiovascular Systems (CSII) United States $1.210B 868.75
VAREX IMAGING (VREX) United States $1.209B 23.67
AtriCure (ATRC) United States $1.055B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.851B 24.35
Cerus (CERS) United States $0.808B 0.00
MacroGenics (MGNX) United States $0.796B 0.00
NanoString Technologies (NSTG) United States $0.744B 0.00
TG Therapeutics (TGTX) United States $0.699B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.676B 23.00
Evolus (EOLS) United States $0.665B 0.00
OraSure Technologies (OSUR) United States $0.585B 25.46
Surmodics (SRDX) United States $0.569B 82.72
LeMaitre Vascular (LMAT) United States $0.539B 25.61
Meridian Bioscience (VIVO) United States $0.534B 15.90
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.330B 0.00
Insys Therapeutics (INSY) United States $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.90
BioLife Solutions (BLFS) United States $0.303B 125.08
Vapotherm (VAPO) United States $0.281B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.170B 18.21
Chimerix (CMRX) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.132B 0.00
Fonar (FONR) United States $0.123B 6.59
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Neurotrope (NTRP) United States $0.078B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00